Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cabometyx
Pharma
Merck's Welireg combos deliver 1-2 punch to kidney cancer
One critical factor could hinder these Welireg regimens from shifting from potential treatment options to the universal standard of care.
Angus Liu
Feb 28, 2026 10:00am
Exelixis aims to be a top 5 solid tumor drugmaker in the US: CEO
Jan 16, 2026 1:00pm
ExCellThera's novel blood cancer cell therapy gains CHMP nod
Jun 20, 2025 11:55am
FDA recognizes 'crossover impact' on survival in Cabometyx nod
Mar 26, 2025 11:03am
Exelixis shifts focus as triplet misses OS mark in kidney cancer
Feb 18, 2025 1:30pm
FDA cancels adcomm for Cabometyx in neuroendocrine tumors
Jan 10, 2025 9:46am
